The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

By Barchfeld G.L.   Hessler A.L.   Chen M.   Pizza M.   Rappuoli R.   Van Nest G.A.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 695-704

Elsevier

Access to resources Recommend Favorite

Are We Too Fixated on Clinical Trial Data? The Case for Using Embedded Case Histories to Influence Prescribing

By Black Iain  

Health Marketing Quarterly, Vol. 23, Iss. 1, 2006-07 ,pp. : 3-19

Haworth Press

Access to resources Recommend Favorite

The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines

By Baudner B.C.   Giuliani M.M.   Verhoef J.C.   Rappuoli R.   Junginger H.E.   Giudice G.D.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3837-3844

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

By Jacquet A.   Haumont M.   Massaer M.   Garcia L.   Mazzu P.   Daminet V.   Gregoire D.   Jacobs P.   Bollen A.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1593-1602

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana

By Gonzalez C.R.   Noriega F.R.   Huerta S.   Santiago A.   Vega M.   Paniagua J.   Ortiz-Navarrete V.   Isibasi A.   Levine M.M.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1043-1052

Elsevier

Access to resources Recommend Favorite